Übersetzung für "Drug discontinuation" in Deutsch

These adverse reactions were not associated with an elevated rate of drug discontinuation.

If a patient experiences such events, drug discontinuation should be considered.

The majority was resolved without any treatment and none necessitated drug discontinuation.

Due to the long drug elimination half-life, these events may occur or progress after drug discontinuation.

Due to the long drug elimination half-life, fusion may occur or progress after drug discontinuation.

If parkinsonian symptoms persist more than 4 months after drug discontinuation, a neurologist opinion should be sought.

The incidence of the primary efficacy endpoint defined as first recurrence of AF or premature study drug discontinuation for intolerance or lack of efficacy at 12 months was 75% in the dronedarone group and 59% in the amiodarone group (hazard ratio = 1.59, log-rank p-value < 0.0001).

The incidence of the main safety endpoint defined as the occurrence of thyroid, hepatic, pulmonary, neurological, skin, eye or gastrointestinal specific events or premature study drug discontinuation following any adverse event was reduced by 20% in the dronedarone group compared to the amiodarone group (p = 0.129).

This compares to approximately 40% seen in earlier studies in which measurements occurred after drug discontinuation over a similar period of observation.

Bleeding was the most common adverse reaction leading to study drug discontinuation for both treatments (3.0% for Zontivity and 1.8% for placebo).

For post-MI or PAD patients with no history of stroke or TIA, the rate of study drug discontinuation because of adverse reactions was 6.8% for Zontivity and 6.9% for placebo.

If parkinsonian symptoms persist more than four months after drug discontinuation, a neurologist opinion should be sought.